Department of Internal Medicine
Hypertension and Vascular Diseases,
The Medical University of Warsaw,
Banacha Street 1A, 02-097 Warsaw, Poland
Tel: +48 22 599 28 28
Fax: +48 22 599 18 28
E-mail address: cezary{at}amwaw.edu.pl
gorzata Raczkowska
Department of Internal Medicine
Hypertension and Vascular Diseases
The Medical University of Warsaw
Warsaw, Poland
Department of Internal Medicine
Hypertension and Vascular Diseases
The Medical University of Warsaw
Warsaw, Poland
Department of Internal Medicine
Hypertension and Vascular Diseases
The Medical University of Warsaw
Warsaw, Poland
Department of Internal Medicine
Hypertension and Vascular Diseases
The Medical University of Warsaw
Warsaw, Poland
Johan Sundström et al.1 presented their very interesting data linking TIMP-1 levels to cardiovascular risk factors, including left ventricular hypertrophy. As the authors mentioned, TIMP-1 levels were previously measured in a number of cardiovascular diseases, such as hypertension, coronary disease, and heart failure, but the groups studied were smaller and results were inconsistent. Plasma TIMP-1 levels seem to be more often used than other possible biochemical parameters of collagen metabolism, at least in cardiovascular patients.25 However, not only increased left ventricular mass, but also increased intima media thickness of the common carotid arteries (IMT) can serve as an independent risk factor for cardiovascular events. Increased IMT may be related to the accumulation of extracellular proteins due to altered metabolism of collagen. Comparing patients with untreated essential hypertension with healthy controls, we found not only increased IMT in the former, but also significantly elevated plasma TIMP-1 levels. Moreover, we found a significant, positive correlation between IMT and the levels of TIMP-1 in hypertensives, but not in healthy subjects.6 We think that TIMP-1 level may be a biomarker of the remodelling of the entire cardiovascular system, not only the left ventricle of the heart.
References
|